-
EP4056581
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4056581
| EP4056581 - POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.08.2022 Database last updated on 27.07.2024 | |
| Former | The international publication has been made Status updated on 14.05.2021 | Most recent event Tooltip | 17.04.2024 | The date on which the examining division becomes responsible, has been established | 17.04.2024 | Amendment by applicant | Applicant(s) | For all designated states Taisho Pharmaceutical Co., Ltd. 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633 / JP | [2022/37] | Inventor(s) | 01 /
HAYASHI, Masato c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome, Toshima-ku Tokyo 170-8633 / JP | 02 /
TAKEUCHI, Tomoki c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome, Toshima-ku Tokyo 170-8633 / JP | 03 /
NOMURA, Yusaku c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome, Toshima-ku Tokyo 170-8633 / JP | 04 /
TAMITA, Tomoko c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome, Toshima-ku Tokyo 170-8633 / JP | 05 /
SHIMONO, Rie c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takada 3-chome, Toshima-ku Tokyo 170-8633 / JP | [2022/37] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2022/37] | Application number, filing date | 20883820.1 | 06.11.2020 | [2022/37] | WO2020JP42350 | Priority number, date | JP20190203338 | 08.11.2019 Original published format: JP 2019203338 | [2022/37] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021090959 | Date: | 14.05.2021 | Language: | JA | [2021/19] | Type: | A1 Application with search report | No.: | EP4056581 | Date: | 14.09.2022 | Language: | EN | [2022/37] | Search report(s) | International search report - published on: | JP | 14.05.2021 | (Supplementary) European search report - dispatched on: | EP | 27.10.2023 | Classification | IPC: | C07K7/06, A61K38/07, A61K38/08, A61P35/00, A61P43/00, C12N9/99, C07C311/29, C07K5/113 | [2023/48] | CPC: |
C07K7/02 (EP);
A61K38/07 (IL,US);
C07K7/06 (CN,IL,KR,US);
A61K38/00 (EP,KR);
A61K38/08 (CN,IL,US);
A61P35/00 (EP,CN,IL,KR);
|
| Former IPC [2022/37] | C07K7/06, A61K38/07, A61K38/08, A61P35/00, A61P43/00, C12N9/99 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/37] | Extension states | BA | 03.06.2022 | ME | 03.06.2022 | Title | German: | POLYPEPTID MIT MMP2-HEMMENDER WIRKUNG | [2022/37] | English: | POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT | [2022/37] | French: | POLYPEPTIDE AYANT UN EFFET INHIBITEUR SUR LES MMP2 | [2022/37] | Entry into regional phase | 03.06.2022 | Translation filed | 03.06.2022 | National basic fee paid | 03.06.2022 | Search fee paid | 03.06.2022 | Designation fee(s) paid | 03.06.2022 | Examination fee paid | Examination procedure | 03.06.2022 | Examination requested [2022/37] | 17.04.2024 | Amendment by applicant (claims and/or description) | 17.04.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 24.11.2022 | Renewal fee patent year 03 | 13.11.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2013001297 (ITI SCOTLAND LTD [GB], et al); | International search | [A]JP2009235071 (NOVARTIS AG); | [YA]US2011171133 (VAN ECK-SMIT BERTHA LOUISE FREDERIKE [NL], et al); | [A]JP2014526459 ; | [YA]JP2018197251 (CAREGEN CO LTD); |